Clinical Trial Update: PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PET/CT and WB MRI for staging and response in metastatic prostate cancer patients receiving enzalutamide has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: The European Uro-Oncology Group | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED